2500x1875-bg.jpg
2500x1875bg2.jpg
2500x1875bg8.jpg
2500x1875bg4.jpg
2500x1875bg6.jpg
2500x1875-bg.jpg

Stelvio Oncology


Stelvio Oncology has developed an epigenetic signature based platform for identifying compounds that drive differentiation of cancer stem cells into benign cell types

SCROLL DOWN

Stelvio Oncology


Stelvio Oncology has developed an epigenetic signature based platform for identifying compounds that drive differentiation of cancer stem cells into benign cell types

 

Stelvio Oncology is developing a personalized approach to glioblastoma treatment. Our team has core competencies of scientific creativity, clinical excellence and professional management required to successfully commercialize novel drug therapies and precision medicine diagnostics.

 
2500x1875bg2.jpg

Personalizing


The biggest problem in cancer remains drug resistance and loss of response to treatment which ultimately leads to no viable alternatives for patients. We are targeting cancer stem cell fates which have resistance mechanisms.
 

Personalizing


The biggest problem in cancer remains drug resistance and loss of response to treatment which ultimately leads to no viable alternatives for patients. We are targeting cancer stem cell fates which have resistance mechanisms.
 

2500x1875bg8.jpg

Novel cancer treatments


Our team is focusing on developing a personalized approach to glioblastoma treatment.

Novel cancer treatments


Our team is focusing on developing a personalized approach to glioblastoma treatment.

2500x1875bg4.jpg

Precision Medicine


Precision Medicine:
Personalized Approach
to Treating Glioblastoma.

Precision Medicine


Precision Medicine:
Personalized Approach
to Treating Glioblastoma.

2500x1875bg6.jpg

Identifying resistance mechanisms


Identifying resistance
mechanisms which can be
overcome with targeted
therapies.

Identifying resistance mechanisms


Identifying resistance
mechanisms which can be
overcome with targeted
therapies.